• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

OptiMedica partners with Topcon Medical Japan

Article

OptiMedica Corp. will be expanding into Japan with the formation of an exclusive distribution agreement with Topcon Medical Japan Co., Ltd.

Santa Clara, CA-OptiMedica Corp. will be expanding into Japan with the formation of an exclusive distribution agreement with Topcon Medical Japan Co., Ltd.

According to the terms of the agreement, Topcon Medical Japan will be the sole local distributor of OptiMedica's pattern scan laser photocoagulator system (PASCAL), which is designed to treat a variety of retinal conditions including diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusive disease.

"Topcon Medical Japan has a solid history of service to the ophthalmology community and has demonstrated a deep commitment to superior customer care," said Jean-Robert Strele, vice president of international business, OptiMedica. "These values are important to OptiMedica, and we look forward to entering this important partnership to serve the interests of Japanese ophthalmologists and patients."

"We strongly believe that adding the [photocoagulator] to our portfolio of outstanding products . . . will allow us to meet the needs of advanced medical care in the Japanese ophthalmic community,"said Hiroshi Fukuzawa, director, executive officer, and general manager of the Eye Care Business Unit of Topcon Medical Japan.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.